The nation of Zimbabwe has turned down a substantial American health deal valued at 367 million US dollars (272 million pounds) over five years over the United States' demand for confidential data.
The decision came to light following a internal memorandum from December was leaked, which showed Head of State Emmerson Mnangagwa felt the deal was "skewed".
An official spokesperson has since explained that the United States was seeking genetic material for scientific study and commercial purposes while refused to share the resulting advantages from future medical innovations.
"We are forced to start the challenging and unfortunate process of winding down our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the United States had provided more than $1.9bn for health programmes to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has urged more dialogue to find a deal suitable to both sides so the nation's vital HIV programme can be sustained.
Wider Context
This rejection follows a similar situation in neighbouring Kenya, where a court blocked a related deal with the US after concerns were raised about the safety of citizens' health data.
After returning to office last year, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
The agency had managed aid for the US government, but Trump argued its spending was "wasteful" and his administration was seeking government-to-government agreements to boost openness and accountability.
According to statements, Sixteen African countries have so far signed these new health pacts, constituting more than $18.3bn of fresh investment.
Details of the Rejected Agreement
The funds for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this cooperation would have delivered immense benefits for Zimbabwean communities, especially the 1.2 million presently receiving antiretroviral therapy through US-supported programmes," the Ambassador said.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"Our nation was requested to surrender its genetic material and health information over an extended period, with no equivalent assurance of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that shared data," he stated.
"In essence, our nation would provide the basic resources for scientific discovery with no assurance that the final treatments would be available to our population if a new health crisis emerge."
National Interest and International Frameworks
He also pointed out that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were disrupting frameworks previously established via the international organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme created to manage future pandemics.
"This system is intended to guarantee that when a country provides its information, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to create them."
These objections regarding the US deal "are not meant as anti-American sentiment," he added.
"We welcome further discussions with our US partners on how subsequent collaboration could be structured in a manner that respects the sovereignty and dignity of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the official position, but suggested that negotiations should continue since much of the nation's HIV programmes depended on external financing.
"In cases where technical issues exist, such as those relating to data governance or implementation frameworks, these can frequently be resolved via detailed discussion and mutually agreed protections," it added.
The situation underscores the continuing tensions between accepting crucial international aid and safeguarding national sovereignty in an increasingly interconnected world.